{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:30:49Z","timestamp":1790721049887,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Transition funds provided by Dutch health insurers"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10620-025-09030-x","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:04:22Z","timestamp":1744884262000},"page":"2097-2104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study"],"prefix":"10.1007","volume":"70","author":[{"given":"Natasja","family":"van de Pol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyke H.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"van Noord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Janneke","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"9030_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.suc.2019.08.001","volume":"99","author":"S Flynn","year":"2019","unstructured":"Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin N Am 2019;99:1051\u20131062.","journal-title":"Surg Clin N Am"},{"key":"9030_CR2","first-page":"235","volume":"7","author":"JS Levine","year":"2011","unstructured":"Levine JS, Burakoff R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2011;7:235\u2013241.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"9030_CR3","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641\u20131657.","journal-title":"Lancet"},{"key":"9030_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12325-019-01151-w","volume":"37","author":"A Nocerino","year":"2020","unstructured":"Nocerino A, Nguyen A, Agrawal M et al. Fatigue in inflammatory bowel diseases: etiologies and management. Adv Ther 2020;37:97\u2013112.","journal-title":"Adv Ther"},{"key":"9030_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ecco-jcc\/jjv091","volume":"9","author":"T Grimstad","year":"2015","unstructured":"Grimstad T, Norheim KB, Isaksen K et al. Fatigue in newly diagnosed inflammatory bowel disease. J Crohns Colitis 2015;9:725\u2013730.","journal-title":"J Crohns Colitis"},{"key":"9030_CR6","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ibd\/izy015","volume":"24","author":"SR Knowles","year":"2018","unstructured":"Knowles SR, Keefer L, Wilding H et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-Part II. Inflamm Bowel Dis 2018;24:966\u2013976.","journal-title":"Inflamm Bowel Dis"},{"key":"9030_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/CEG.S120816","volume":"11","author":"M Engels","year":"2018","unstructured":"Engels M, Cross RK, Long MD. Exercise in patients with inflammatory bowel diseases: current perspectives. Clin Exp Gastroenterol 2018;11:1\u201311.","journal-title":"Clin Exp Gastroenterol"},{"key":"9030_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000511212","volume":"6","author":"G Fagan","year":"2021","unstructured":"Fagan G, Osborne H, Schultz M. Physical activity in patients with inflammatory bowel disease: a cross-sectional study. Inflamm Intest Dis 2021;6:61\u201369.","journal-title":"Inflamm Intest Dis"},{"key":"9030_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100171","volume":"6","author":"T Agrawal","year":"2021","unstructured":"Agrawal T, Acquah I, Dey AK et al. Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease. Am J Prev Cardiol 2021;6:100171.","journal-title":"Am J Prev Cardiol"},{"key":"9030_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/JSM.0b013e31802b4fda","volume":"17","author":"V Ng","year":"2007","unstructured":"Ng V, Millard W, Lebrun C, Howard J. Low-intensity exercise improves quality of life in patients with Crohn\u2019s disease. Clin J Sport Med 2007;17:384\u2013388.","journal-title":"Clin J Sport Med"},{"key":"9030_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1572-0241.1999.00939.x","volume":"94","author":"CP Loudon","year":"1999","unstructured":"Loudon CP, Corroll V, Butcher J et al. The effects of physical exercise on patients with Crohn\u2019s disease. Am J Gastroenterol 1999;94:697\u2013703.","journal-title":"Am J Gastroenterol"},{"key":"9030_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/flgastro-2013-100339","volume":"5","author":"D Chan","year":"2014","unstructured":"Chan D, Robbins H, Rogers S et al. Inflammatory bowel disease and exercise: results of a Crohn\u2019s and Colitis UK survey. Frontline Gastroenterol 2014;5:44\u201348.","journal-title":"Frontline Gastroenterol"},{"key":"9030_CR13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749\u2013753.","journal-title":"Gut"},{"key":"9030_CR14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000201455","volume":"58","author":"MG Russel","year":"1997","unstructured":"Russel MG, Pastoor CJ, Brandon S et al. Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease. Digestion 1997;58:282\u2013288.","journal-title":"Digestion"},{"key":"9030_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s41687-023-00642-3","volume":"7","author":"AMH Stoker","year":"2023","unstructured":"Stoker AMH, Gruters A, Loon M et al. Translation, validation and psychometric properties of the Dutch version of the Inflammatory Bowel Disease-Fatigue (IBD-F) self-assessment scale. J Patient Rep Outcomes 2023;7:108.","journal-title":"J Patient Rep Outcomes"},{"key":"9030_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00365521.2020.1857430","volume":"56","author":"ME de Jong","year":"2021","unstructured":"de Jong ME, Taal E, Thomas PWA et al. Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroenterol 2021;56:155\u2013161.","journal-title":"Scand J Gastroenterol"},{"key":"9030_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000371795","volume":"91","author":"P Klare","year":"2015","unstructured":"Klare P, Nigg J, Nold J et al. The impact of a ten-week physical exercise program on health-related quality of life in patients with inflammatory bowel disease: a prospective randomized controlled trial. Digestion 2015;91:239\u2013247.","journal-title":"Digestion"},{"key":"9030_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10620-020-06222-5","volume":"66","author":"LW van Erp","year":"2021","unstructured":"van Erp LW, Roosenboom B, Komdeur P et al. Improvement of fatigue and quality of life in patients with quiescent inflammatory bowel disease following a personalized exercise program. Dig Dis Sci 2021;66:597\u2013604. https:\/\/doi.org\/10.1007\/s10620-020-06222-5","journal-title":"Dig Dis Sci"},{"key":"9030_CR19","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1\u2013s106.","journal-title":"Gut"},{"key":"9030_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.gcb.2009.08.015","volume":"35","author":"AC Lesage","year":"2011","unstructured":"Lesage AC, Hag\u00e8ge H, Tucat G, Gendre JP. Results of a national survey on quality of life in inflammatory bowel diseases. Clin Res Hepatol Gastroenterol 2011;35:117\u2013124.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"9030_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2023.101672","volume":"70","author":"S Khan","year":"2024","unstructured":"Khan S, Sebastian SA, Parmar MP et al. Factors influencing the quality of life in inflammatory bowel disease: a comprehensive review. Dis Mon 2024;70:101672.","journal-title":"Dis Mon"},{"key":"9030_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/00365520310008386","volume":"39","author":"T Bernklev","year":"2004","unstructured":"Bernklev T, Jahnsen J, Aadland E et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004;39:365\u2013373.","journal-title":"Scand J Gastroenterol"},{"key":"9030_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026290","volume":"100","author":"B Kim","year":"2021","unstructured":"Kim B, Chae J, Kim EH et al. Physical activity and quality of life of patients with inflammatory bowel disease. Medicine (Baltimore) 2021;100:e26290.","journal-title":"Medicine (Baltimore)"},{"key":"9030_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12876-021-01739-z","volume":"21","author":"CR Lamers","year":"2021","unstructured":"Lamers CR, de Roos NM, Koppelman LJM et al. Patient experiences with the role of physical activity in inflammatory bowel disease: results from a survey and interviews. BMC Gastroenterol 2021;21:172.","journal-title":"BMC Gastroenterol"},{"key":"9030_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/2050640620936383","volume":"8","author":"WA Seeger","year":"2020","unstructured":"Seeger WA, Thieringer J, Esters P et al. Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn\u2019s disease. United Eur Gastroenterol J 2020;8:804\u2013813.","journal-title":"United Eur Gastroenterol J"},{"key":"9030_CR26","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/apt.16002","volume":"52","author":"K Jones","year":"2020","unstructured":"Jones K, Baker K, Speight RA et al. Randomised clinical trial: combined impact and resistance training in adults with stable Crohn\u2019s disease. Aliment Pharmacol Ther 2020;52:964\u2013975.","journal-title":"Aliment Pharmacol Ther"},{"key":"9030_CR27","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/ijerph18042023","volume":"18","author":"D Collado-Mateo","year":"2021","unstructured":"Collado-Mateo D, Lav\u00edn-P\u00e9rez AM, Pe\u00f1acoba C et al. Key factors associated with adherence to physical exercise in patients with chronic diseases and older adults: an umbrella review. Int J Environ Res Public Health 2021;18:2023.","journal-title":"Int J Environ Res Public Health"},{"key":"9030_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afad023","author":"MB Pinheiro","year":"2023","unstructured":"Pinheiro MB, Howard K, Oliveira JS et al. Cost-effectiveness of physical activity programs and services for older adults: a scoping review. Age Ageing. 2023. https:\/\/doi.org\/10.1093\/ageing\/afad023.","journal-title":"Age Ageing"},{"key":"9030_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12913-023-09556-8","volume":"23","author":"M Duijvestijn","year":"2023","unstructured":"Duijvestijn M, de Wit GA, van Gils PF, Wendel-Vos GCW. Impact of physical activity on healthcare costs: a systematic review. BMC Health Serv Res 2023;23:572.","journal-title":"BMC Health Serv Res"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-09030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-09030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:39:15Z","timestamp":1757158755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-09030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["9030"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-09030-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DvN has served on advisory boards for Janssen, Takeda, Abbvie, Galapagos, and Lilly; CJW received grants from ZonMW, Falk, and Pfizer, has received consulting fees from Janssen, Galapagos, and Pfizer, has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Ferring and AbbVie, and had leadership roles in the European Crohn\u2019s & Colitis organization and United European Gastroenterology council and the Dutch Association for Gastroenterology (NVGE); ACV has served on advisory boards for Takeda, Janssen, Bristol Myers Squibb, Abbvie, Pfizer, and Galapagos and has received unrestricted research grants from Takeda, Janssen, and Pfizer; RLW has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Ferring, Pfizer, Galapagos, AbbVie, and Janssen; all other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Erasmus University Medical Center, MEC-2022-0737.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}